annual CFI:
$121.41M+$342.52M(+154.91%)Summary
- As of today (July 26, 2025), ABCL annual cash flow from investing activities is $121.41 million, with the most recent change of +$342.52 million (+154.91%) on December 31, 2024.
- During the last 3 years, ABCL annual CFI has risen by +$453.66 million (+136.54%).
- ABCL annual CFI is now at all-time high.
Performance
ABCL Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$7.93M-$27.77M(-77.77%)Summary
- As of today (July 26, 2025), ABCL quarterly cash flow from investing activities is $7.93 million, with the most recent change of -$27.77 million (-77.77%) on March 31, 2025.
- Over the past year, ABCL quarterly CFI has dropped by -$21.98 million (-73.47%).
- ABCL quarterly CFI is now -84.77% below its all-time high of $52.10 million, reached on June 30, 2024.
Performance
ABCL quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$99.43M-$21.98M(-18.10%)Summary
- As of today (July 26, 2025), ABCL TTM cash flow from investing activities is $99.43 million, with the most recent change of -$21.98 million (-18.10%) on March 31, 2025.
- Over the past year, ABCL TTM CFI has increased by +$141.02 million (+339.09%).
- ABCL TTM CFI is now -18.10% below its all-time high of $121.41 million, reached on December 31, 2024.
Performance
ABCL TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ABCL Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +154.9% | -73.5% | +339.1% |
| 3 y3 years | +136.5% | +130.1% | +129.0% |
| 5 y5 years | +2200.5% | +242.1% | +1389.2% |
ABCL Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +134.4% | -84.8% | +102.8% | -18.1% | +120.6% |
| 5 y | 5-year | at high | +134.4% | -84.8% | +102.8% | -18.1% | +120.6% |
| alltime | all time | at high | +134.4% | -84.8% | +102.8% | -18.1% | +120.6% |
ABCL Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $7.93M(-77.8%) | $99.43M(-18.1%) |
| Dec 2024 | $121.41M(-154.9%) | $35.70M(+865.5%) | $121.41M(+97.8%) |
| Sep 2024 | - | $3.70M(-92.9%) | $61.38M(+36.7%) |
| Jun 2024 | - | $52.10M(+74.2%) | $44.90M(-208.0%) |
| Mar 2024 | - | $29.91M(-223.0%) | -$41.59M(-81.2%) |
| Dec 2023 | -$221.11M(-37.3%) | -$24.32M(+90.2%) | -$221.11M(+3.4%) |
| Sep 2023 | - | -$12.79M(-62.8%) | -$213.85M(-55.7%) |
| Jun 2023 | - | -$34.39M(-77.0%) | -$483.06M(+1.5%) |
| Mar 2023 | - | -$149.61M(+776.8%) | -$475.86M(+34.9%) |
| Dec 2022 | -$352.63M | -$17.06M(-93.9%) | -$352.63M(+4.7%) |
| Sep 2022 | - | -$281.99M(+936.9%) | -$336.71M(+3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$27.20M(+3.1%) | -$324.34M(-5.4%) |
| Mar 2022 | - | -$26.37M(+2195.1%) | -$342.78M(+3.2%) |
| Dec 2021 | -$332.25M(+177.4%) | -$1.15M(-99.6%) | -$332.25M(-24.4%) |
| Sep 2021 | - | -$269.63M(+490.9%) | -$439.28M(+153.1%) |
| Jun 2021 | - | -$45.63M(+188.1%) | -$173.54M(+33.5%) |
| Mar 2021 | - | -$15.84M(-85.4%) | -$130.04M(+8.6%) |
| Dec 2020 | -$119.78M(+1972.3%) | -$108.18M(+2684.6%) | -$119.78M(+932.8%) |
| Sep 2020 | - | -$3.88M(+82.4%) | -$11.60M(+50.4%) |
| Jun 2020 | - | -$2.13M(-61.8%) | -$7.71M(+38.2%) |
| Mar 2020 | - | -$5.58M | -$5.58M |
| Dec 2019 | -$5.78M(+8.9%) | - | - |
| Dec 2018 | -$5.31M | - | - |
FAQ
- What is AbCellera Biologics Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. annual CFI year-on-year change?
- What is AbCellera Biologics Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. quarterly CFI year-on-year change?
- What is AbCellera Biologics Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for AbCellera Biologics Inc.?
- What is AbCellera Biologics Inc. TTM CFI year-on-year change?
What is AbCellera Biologics Inc. annual cash flow from investing activities?
The current annual CFI of ABCL is $121.41M
What is the all time high annual CFI for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high annual cash flow from investing activities is $121.41M
What is AbCellera Biologics Inc. annual CFI year-on-year change?
Over the past year, ABCL annual cash flow from investing activities has changed by +$342.52M (+154.91%)
What is AbCellera Biologics Inc. quarterly cash flow from investing activities?
The current quarterly CFI of ABCL is $7.93M
What is the all time high quarterly CFI for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high quarterly cash flow from investing activities is $52.10M
What is AbCellera Biologics Inc. quarterly CFI year-on-year change?
Over the past year, ABCL quarterly cash flow from investing activities has changed by -$21.98M (-73.47%)
What is AbCellera Biologics Inc. TTM cash flow from investing activities?
The current TTM CFI of ABCL is $99.43M
What is the all time high TTM CFI for AbCellera Biologics Inc.?
AbCellera Biologics Inc. all-time high TTM cash flow from investing activities is $121.41M
What is AbCellera Biologics Inc. TTM CFI year-on-year change?
Over the past year, ABCL TTM cash flow from investing activities has changed by +$141.02M (+339.09%)